Ryan Allway May 19th, 2021 LONDON and TORONTO, May 18, 2021 /PRNewswire/ – Apollon Formularies plc (AQSE: APOL) (“Apollon” or the “Company”), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc. (CSE: AION) (“Aion”), a BC based international pharmaceutical company trading on the Canadian Securities Exchange, are pleased to announce that joint testing has revealed... Read more